These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19485917)

  • 21. The cardioprotective effects of statins.
    Eto M; Lüscher TF
    Coron Artery Dis; 2004 Aug; 15(5):243-5. PubMed ID: 15238819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease.
    Lefer AM; Scalia R; Lefer DJ
    Cardiovasc Res; 2001 Feb; 49(2):281-7. PubMed ID: 11164838
    [No Abstract]   [Full Text] [Related]  

  • 24. Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.
    Rosenson RS
    Am J Cardiovasc Drugs; 2001; 1(6):411-20. PubMed ID: 14728000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
    Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
    Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Mason RP; Walter MF; Day CA; Jacob RF
    Am J Cardiol; 2005 Sep; 96(5A):11F-23F. PubMed ID: 16126019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant effects of statins.
    Stoll LL; McCormick ML; Denning GM; Weintraub NL
    Timely Top Med Cardiovasc Dis; 2005 Feb; 9():E1. PubMed ID: 15824760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pleiotropic effects of statins on endothelium and signaling mechanisms].
    Shiota M; Izumi Y; Nakao T; Iwao H
    Nihon Yakurigaku Zasshi; 2006 Sep; 128(3):161-6. PubMed ID: 16971779
    [No Abstract]   [Full Text] [Related]  

  • 30. Statins and cardioprotection--more than just lipid lowering?
    Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia.
    Weber C; Erl W; Weber KS; Weber PC
    J Am Coll Cardiol; 1997 Nov; 30(5):1212-7. PubMed ID: 9350917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antioxidant effects of statins.
    Stoll LL; McCormick ML; Denning GM; Weintraub NL
    Drugs Today (Barc); 2004 Dec; 40(12):975-90. PubMed ID: 15645009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond lipid-lowering: effects of statins on endothelial nitric oxide.
    Laufs U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):719-31. PubMed ID: 12634978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleiotropic Effects of Statins on the Cardiovascular System.
    Oesterle A; Laufs U; Liao JK
    Circ Res; 2017 Jan; 120(1):229-243. PubMed ID: 28057795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
    Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
    Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential vascular benefits of statins.
    Kinlay S
    Am J Med; 2005 Dec; 118 Suppl 12A():62-7. PubMed ID: 16356810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
    Bi XY; He X; Zhao M; Yu XJ; Zang WJ
    J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.
    Liuni A; Luca MC; Gori T; Parker JD
    Clin Hemorheol Microcirc; 2010; 45(2-4):161-7. PubMed ID: 20675896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endothelium-dependent effects of statins.
    Wolfrum S; Jensen KS; Liao JK
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):729-36. PubMed ID: 12615672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP; Walter MF; Jacob RF
    Circulation; 2004 Jun; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.